Literature DB >> 21444235

The global need for effective antibiotics-moving towards concerted action.

Otto Cars1, Anna Hedin, Andreas Heddini.   

Abstract

Antibiotic resistance has emerged as one of the greatest global health challenges to be addressed in the 21st Century. The risk of widespread antibiotic resistance threatens to mitigate the positive changes made in modernizing healthcare systems; therefore, fresh approaches are essential, as well as new and effective antibacterial drugs. In a globalized world, a spectrum of different interventions and health technologies must be employed to contain antibiotic resistance. Finding ways of accelerating the development of new drugs and diagnostic tools is one strategy, as is better surveillance of antibiotic resistance and ways of improving use of existing antibiotics. Moreover, a framework to regulate use is called for to avoid that potential new antibiotics are squandered. Finally, the ongoing pandemic spread of resistant bacteria illustrates that the problem can only be addressed through international cooperation and thus that any new strategy to manage antibiotic resistance must take into consideration issues of global access and affordability.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Mesh:

Substances:

Year:  2011        PMID: 21444235     DOI: 10.1016/j.drup.2011.02.006

Source DB:  PubMed          Journal:  Drug Resist Updat        ISSN: 1368-7646            Impact factor:   18.500


  16 in total

1.  Isolation and Structural Elucidation of Brevibacillin, an Antimicrobial Lipopeptide from Brevibacillus laterosporus That Combats Drug-Resistant Gram-Positive Bacteria.

Authors:  Xu Yang; En Huang; Chunhua Yuan; Liwen Zhang; Ahmed E Yousef
Journal:  Appl Environ Microbiol       Date:  2016-04-18       Impact factor: 4.792

2.  Microfluidic advances in phenotypic antibiotic susceptibility testing.

Authors:  Jennifer Campbell; Christine McBeth; Maxim Kalashnikov; Anna K Boardman; Andre Sharon; Alexis F Sauer-Budge
Journal:  Biomed Microdevices       Date:  2016-12       Impact factor: 2.838

Review 3.  Recent Advances in Oral Nano-Antibiotics for Bacterial Infection Therapy.

Authors:  Ze-Liang Wu; Jun Zhao; Rong Xu
Journal:  Int J Nanomedicine       Date:  2020-12-01

4.  Identification of a new Bacillus licheniformis strain producing a bacteriocin-like substance.

Authors:  Yaoqi Guo; Zhanqiao Yu; Jianhua Xie; Rijun Zhang
Journal:  J Microbiol       Date:  2012-06-30       Impact factor: 3.422

5.  Terpenoid bioactive compound from Streptomyces rochei (M32): taxonomy, fermentation and biological activities.

Authors:  Raasaiyah Pazhanimurugan; Manikkam Radhakrishnan; Thangavel Shanmugasundaram; Venugopal Gopikrishnan; Ramasamy Balagurunathan
Journal:  World J Microbiol Biotechnol       Date:  2016-08-25       Impact factor: 3.312

6.  Acquired genetic mechanisms of a multiresistant bacterium isolated from a treatment plant receiving wastewater from antibiotic production.

Authors:  Anna Johnning; Edward R B Moore; Liselott Svensson-Stadler; Yogesh S Shouche; D G Joakim Larsson; Erik Kristiansson
Journal:  Appl Environ Microbiol       Date:  2013-09-13       Impact factor: 4.792

7.  Inhibition of ribosomal subunit synthesis in Escherichia coli by the vanadyl ribonucleoside complex.

Authors:  Ashley D Frazier; W Scott Champney
Journal:  Curr Microbiol       Date:  2013-03-20       Impact factor: 2.188

8.  Impact of FtsZ Inhibition on the Localization of the Penicillin Binding Proteins in Methicillin-Resistant Staphylococcus aureus.

Authors:  Edgar Ferrer-González; Hyun Huh; Hassan M Al-Tameemi; Jeffrey M Boyd; Sang-Hyuk Lee; Daniel S Pilch
Journal:  J Bacteriol       Date:  2021-07-22       Impact factor: 3.490

9.  Securing access to effective antibiotics for current and future generations. Whose responsibility?

Authors:  Otto Cars
Journal:  Ups J Med Sci       Date:  2014-04-27       Impact factor: 2.384

10.  Decreased Antibiotic Prescription in an Italian Pediatric Population With Nonspecific and Persistent Upper Respiratory Tract Infections by Use of a Point-of-Care White Blood Cell Count, in Addition to Antibiotic Delayed Prescription Strategy.

Authors:  Luigi Cioffi; Raffaele Limauro; Roberto Sassi; Antonio Boccazzi; Donatella Del Gaizo
Journal:  Glob Pediatr Health       Date:  2016-02-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.